OMADA HEALTH, INC. COMMON STOCK

NASDAQ: OMDA (Omada Health, Inc.)

Kemas kini terakhir: 5 jam lalu

11.87

-0.63 (-5.04%)

Penutupan Terdahulu 12.50
Jumlah Dagangan 1,711,571
Purata Dagangan (3B) 1,328,329
Modal Pasaran 736,387,776
Harga / Pendapatan (P/E TTM) 29.68
Harga / Pendapatan (P/E Ke hadapan) 35.97
Harga / Jualan (P/S) 2.25
Harga / Buku (P/B) 2.69
Julat 52 Minggu
10.28 (-13%) — 25.45 (114%)
Tarikh Pendapatan 5 Nov 2026
Margin Keuntungan 4.21%
Margin Operasi (TTM) 2.06%
EPS Cair (TTM) 0.400
Pertumbuhan Hasil Suku Tahunan (YOY) 34.20%
Jumlah Hutang/Ekuiti (D/E MRQ) 50.99%
Nisbah Semasa (MRQ) 4.18
Aliran Tunai Operasi (OCF TTM) 28.69 M
Aliran Tunai Bebas Leveraj (LFCF TTM) 16.94 M
Pulangan Atas Aset (ROA TTM) 1.35%
Pulangan Atas Ekuiti (ROE TTM) 5.72%

AISkor Stockmoo

-0.6
Hutang rendah. Keuntungan lemah. Kecairan jangka pendek mencukupi. Aliran tunai positif. info
Daripada penilaian laporan AI Insight kami tentang pulangan dijangka berbanding risiko. info NA
Penilaian Relatif info NA
Pertumbuhan Tersirat info NA
Sejarah Penilaian info NA
Pulangan atas Modal info NA
Nilai Pegangan info NA
Premium Risiko info NA
Penilaian Pasaran info NA
Tiada aliran jelas sepanjang tahun lalu. Jauh di bawah paras tertinggi 52 minggu. info
Aliran menurun: harga di bawah purata bergeraknya, dan purata itu sedang menurun. Harga telah jatuh jauh di bawah purata itu. Dagangan lebih tinggi pada hari harga turun. info
Daripada analisis teknikal AI kami terhadap carta. info NA
Corak Lilin info NA
Berita terkini kebanyakannya positif. info
Konsensus Penganalisis info NA
Sentimen Pegangan info NA
Institusi bersih -4.49% daripada saham dalam pemfailan 13F terkini: 153 pemegang menambah, 50 mengurang (suku berakhir 30 Sep 2026). info
Kedudukan jual singkat +59.6% dari 31 Aug hingga 30 Oct 2026, 11.4 hari untuk tutup (FINRA). info
Aktiviti Orang Dalam info NA
Persekitaran pasaran berhati-hati. info
Sektor berbanding Pasaran (6B) NA
Tonggak-tonggak tidak sependapat, jadi skor dilemahkan.
Perolehan sesaham meningkat setiap tahun. Mencatat kerugian dalam tahun-tahun kebelakangan. info
Di bawah garis aliran jangka sederhana. info
Harga rendah berbanding purata 52 minggunya. Turun dalam tempoh 5 tahun. info
Aliran turun bagi ketiga-tiga tempoh. Momentum jangka pendek menurun. info
Tiada isyarat jelas daripada sokongan dan rintangan. info
Skor Akhir -0.61
Tunjuk semua

% Dimiliki oleh Orang Dalam 2.12%
% Dimiliki oleh Institusi 95.66%

Pemilikan

Nama Tarikh Syer Dipegang
Divisadero Street Capital Management, Lp 30 Sep 2026 4,320,160
Cigna Investments Inc /New 30 Sep 2026 3,444,629
Estuary Capital Management Lp 30 Sep 2026 1,338,791
Oberweis Asset Management Inc/ 30 Sep 2026 1,216,266

Tiada data dalam julat masa ini.

Institusi

Pemilikan institusi: 94.44%

Kedudukan Pemegang Saham
Bertambah 153 18,822,397
Berkurang 50 14,111,162
Baharu 63 3,843,683
Dijual habis 19 11,338,750

Pemfailan SEC 13F melalui Nasdaq, pemfailan terkini hingga 30 Sep 2026. Pemfailan tiba sehingga 45 hari selepas setiap suku.

Kedudukan Jual Singkat

Penyelesaian Saham Hari untuk tutup
30 Oct 2026 9,163,783 11.4
15 Oct 2026 8,346,222 6.7
30 Sep 2026 7,452,573 4.4
15 Sep 2026 7,470,777 5.9
31 Aug 2026 5,742,536 6.5
14 Aug 2026 5,887,161 3.1

Data jual singkat FINRA melalui Nasdaq, dilaporkan dua kali sebulan.

8 Positif 1 Negatif 3 Neutral
Tarikh Jenis Butiran
16 Nov 2026 Yahoo Finance Omada Health Presents AI-Powered Meal Feedback Research and 12-Month GLP-1 Care Track Outcomes at ObesityWeek 2026
Omada’s AI-powered Meal Map tool, built to focus on nutrient quality rather than restrictive eating, helped members build meal-tracking habits linked to greater weight loss at week 16. In Omada’s GLP-1 Care Track, 71% of members stayed on their medication for a full year, and those who did lost…
08 Nov 2026 Yahoo Finance Omada: 3 Key Takeaways for Long-Term Investors
Omada's cost to serve fell to an all-time low, and it has seemingly found a way to profit from GLP-1 drugs whether employers pay for them or not.
08 Nov 2026 Yahoo Finance What Changes For Omada Health (OMDA) As It Names A New CEO?
Omada Health (NasdaqGS:OMDA) reported record Q3 results and raised full year revenue guidance on 6 November 2026. Co Founder Sean Duffy will shift from CEO to Executive Chair as part of a planned leadership change. Wei Li Shao is set to take over as Chief Executive Officer in January 2027, pending…
08 Nov 2026 Yahoo Finance Omada Health (OMDA) Stock May Be Fully Priced Following Raised Guidance
Omada Health has seen its stock lose ground in recent weeks, and that pullback now puts a spotlight on a simple question for investors who care about fundamentals: Is the current share price properly reflecting what the company is earning today and what those earnings may reasonably support over…
07 Nov 2026 Yahoo Finance Omada Health (OMDA) Dropped, So What Is Behind The Attention Now?
Omada Health (OMDA) drew fresh attention on 5 November 2026 after lifting full year 2026 revenue guidance to US$344 million to US$346 million, following what management described as its strongest quarter so far. Despite the stronger outlook and record third quarter, Omada Health shares closed at…
06 Nov 2026 Yahoo Finance Omada Health (OMDA) Q3 2026 Earnings Call Transcript
Member tenure rose sharply as a CEO handoff approaches for 2027…
06 Nov 2026 Yahoo Finance Omada Health Q3 2026 Earnings Call Summary
Moby summary of Omada Health's Q3 2026 earnings call…
06 Nov 2026 Yahoo Finance What Omada Health (OMDA) Said on Its Q3 Earnings Call
Omada Health (NASDAQ:OMDA) raised its full-year 2026 revenue and adjusted EBITDA outlook after reporting record quarterly revenue and net income in the third quarter, driven by enrollment and growth in its diabetes and hypertension programs. Revenue rose 34% year over year to $91 million, while net…
06 Nov 2026 Yahoo Finance Omada Health Inc (OMDA) (Q3 2026) Earnings Call Highlights: Record Revenue, Membership Growth, ...
Omada Health Inc (OMDA) delivered its strongest quarter ever with 34% revenue growth, record profitability, and improved member retention, prompting an upward revision of full-year 2026 guidance.
05 Nov 2026 Yahoo Finance Compared to Estimates, Omada Health, Inc. (OMDA) Q3 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Omada Health, Inc. (OMDA) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
05 Nov 2026 Yahoo Finance Omada Health, Inc. (OMDA) Q3 Earnings and Revenues Beat Estimates
Omada Health, Inc. (OMDA) delivered earnings and revenue surprises of +88.89% and +6.48%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
05 Nov 2026 Yahoo Finance Omada Health Reports Third Quarter 2026 Results
Quarterly Revenue of $91 million and All-Time High Total Members of 1.1 millionRevenue Grew 34% and Total Members Increased 36% Year over YearRaises Full Year 2026 Financial Outlook SAN FRANCISCO, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Omada Health, Inc. (Nasdaq: OMDA), the virtual between-visit…
22 Oct 2026 Yahoo Finance PRISM MarketView Highlights Five Innovative Public Companies Supporting Strength and Mobility for National Physical Therapy Month
OrthoPediatrics, Omada Health, Enovis, Myomo and FIGS span the full arc of physical therapy, from childhood care and prevention to recovery and the professionals who deliver it NEW YORK, Oct. 22, 2026 (GLOBE NEWSWIRE) -- PRISM MarketView, a financial media platform covering small and micro-cap…
20 Oct 2026 Yahoo Finance Omada Health to Present Peer-Reviewed Research on Improving Weight Loss and Body Composition During GLP-1 Treatment at World Obesity and Weight Management Congress
The oral presentation will share results from a 12-week comparative study showing that Omada GLP-1 Care Track members, on average, lost more weight and saw greater improvements in body composition than controlsSAN FRANCISCO, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual…
13 Oct 2026 Yahoo Finance Omada Health to Announce Third Quarter 2026 Financial Results and Host Conference Call on November 5, 2026
SAN FRANCISCO, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that it will release its third quarter 2026 results on Thursday, November 5, 2026, after market close, and host a conference call to review the results at…
09 Oct 2026 Yahoo Finance Is Omada Health (OMDA) Cheap As Investors Question Its Long Term Targets?
Omada Health (OMDA) drew fresh attention after its recent share price slide, with the stock down about 6% over the past month and roughly 11% over the past 3 months. Measured over a longer stretch, Omada Health shows a mixed picture, with a strong year to date share price return of 39.73% but a 1…
23 Sep 2026 Yahoo Finance Omada Health President Wei-Li Shao Sells 9,418 Shares for $236,000
Despite selling over 9,000 shares, the insider still holds 307,372 shares.
10 Sep 2026 Yahoo Finance Omada Health to Present Updated Long-Term Financial Targets at Inaugural Investor Day
Omada expects to continue to grow revenue at least 20% annually, and updates long-term non-GAAP gross margin target to 80% and adjusted EBITDA margin target to 30%SAN FRANCISCO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual-first, between-visit healthcare provider…
Papar semua

Isyarat Terkini corak lilin dan silang EMA

▼ Silang maut 7 sesi lalu · 11 Nov
Jangka panjang · EMA 50/200
EMA 50 hari melintas ke bawah EMA 200 hari, tanda yang diperhatikan ramai bahawa arah aliran jangka panjang telah berubah menurun.

Persediaan Teknikal Sederhana

Susunan aliran
Kecerunan
Kemasukan –
Dagangan
Aliran menurun: harga di bawah purata bergeraknya, dan purata itu sedang menurun. Harga telah jatuh jauh di bawah purata itu. Dagangan lebih tinggi pada hari harga turun.
Sokongan terdekat: 10.93 – 12.05 · paras kukuh
Rintangan terdekat: 12.88 – 14.15 · paras kukuh

AI Analisis Teknikal

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Risiko / Ganjaran
TP1:
TP2:

Kerugian hingga SL berbanding keuntungan hingga setiap sasaran, dari EP. Nisbah 2 atau lebih biasanya dicari.

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2026 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda